Ten years ago tomorrow (September 28th, 2010) the United States Food and Drug Administration approved the use of mifepristone along with misoprostol for early term abortions. Data from the Centers for Disease Control show that while the incidence of abortion has remained steady, the share of those performed very early in pregnancy has increased.
Planned Parenthood of the Heartland deserves a medal for seeking to address the geographic (and often economic) disparity in access to abortion in a smart and safe way.
TIME examines government’s role in facilitating abortion access in health care reform proposals; medication abortion has not expanded access as expected; Australian provider refuses to prescribe RU-486 until legal protections are enacted.
This article, one of the worst examples of LifeSiteNews’s consistent mischaracterization of EC, is truly negligent.
Researchers say a recent New York Times piece on off-label misoprostol use misses the point, implying that New York City Latinas are seriously endangering their health while ignoring safe use in countries where abortion is illegal.
Caroline Kennedy seeks Clinton’s Senate seat; as Governor, Napolitano vetoed anti-choice bills, now what?; medication abortion likely to be approved in Italy; birth control to be available over-the-counter in London.
Helped along by Reuters, the Pope delivers his error-riddled opinion on pharmacists, the abortion pill, and emergency contraception.